Likewise, any published information relative to the dosing and administration of reference materials is made available strictly for reference and shall not be construed to encourage the self-administration or any human use of said reference materials
Tesamorelin is owned by Canadian pharmaceutical company Theratechnologies and was approved by the FDA in 2010 for the treatment of lipodystrophy (i.e
Were operating at the frontier, and the responsible posture is to acknowledge that honestly rather than pretend a 30-year safety database exists where it doesnt
Why it was included in the FDA ban Injectable Thymosin Alpha 1 may be linked to immune reactions
Exogenous AAS inhibit endogenous testosterone production, and discontinuation of their use is often associated with a prolonged decrease in testosterone secretion ( The substances used in PCT are administered in the treatment of male hypogonadism unrelated to androgen abuse ( To restore endogenous testosterone, mainly aromatase inhibitors (AIs), selective estrogen receptor modulators (SERMs), and human chorionic gonadotropin (hCG) are used ( In the 2024 WADA Prohibited List ( Aromatase is an enzyme that converts testosterone to estradiol (the most potent estrogen form) and androstenedione to estrone ( The anti-estrogenic compounds mentioned in the WADA list can be divided into two groups: SERMs (bazedoxifene, clomiphene, cyclofenil, ospemifene, raloxifene, tamoxifen, and toremifene) and selective estrogen receptor degraders (SERDs), of which fulvestrant is a representative
Here, we provide the first evidence of delayed aging with a therapeutic mAb, via long-term modulation of IGF-1 action
